Association between accelerometer-determined physical activity and flavonoid-rich fruit and vegetable consumption among a national sample of U.S. adults

P. Loprinzi

DOI: https://doi.org/10.1016/j.pmedr.2015.12.001

IF: 2.813

2015-12-11

Preventive Medicine Reports

Abstract:

What problem does this paper attempt to address?

Potential Maintenance Mechanism in Atrial Fibrillation Patients Subject to Different Treatment Procedures: A Preliminary Study Based on a Human Atrial Model

Zhao-lian Ouyang,Li-ping Sun,Hui Chi,Ling Xia,Ying-lan Gong,Yu-bo Fan

DOI: https://doi.org/10.1007/s11596-018-1895-0

2018-01-01

Current Medical Science

Abstract:Two clinical ablation protocols, 2C3L and stepwise, have been routinely used in our group to treat atrial fibrillation (AF), but with a less than 60% long-term arrhythmia-free outcome achieved in patients. The goal of this study was to examine the underlying mechanism of low success in clinical outcome. MRI images from one patient were used to reconstruct a human atrial anatomical model, and fibrotic tissue was manually added to represent the arrhythmia substrate. AF was induced with standard protocols used in clinical practice. 2C3L and stepwise were then used to test the efficacy of arrhythmia termination in our model. The results showed that re-entries induced in our model could not be terminated by using either 2C3L or the stepwise protocol. Although some of the induced re-entries were terminated, others emerged in new areas. Ablation using only the 2C3L or stepwise method was not sufficient to terminate all re-entries in our model, which may partially explain the poor long-term arrhythmiafree outcomes in clinical practice. Our findings also suggest that computational heart modelling is an important tool to assist in the establishment of optimal ablation strategies.
Analysis of drug-induced and spontaneous cardioversions reveals similar patterns leading to termination of atrial fibrillation

Arne van Hunnik,Vladimír Sobota,Stef Zeemering,Dragan Opacic,Billy Scaf,Elisa D'Alessandro,Karel Oyaert,Marion Kuiper,Jonas G. Diness,Ulrik S. Sørensen,James T. Milnes,Marcel A. G. van der Heyden,Thomas Jespersen,Ulrich Schotten,Sander Verheule

DOI: https://doi.org/10.3389/fphys.2024.1399037

IF: 4

2024-07-18

Frontiers in Physiology

Abstract:Introduction: The mechanisms leading to the conversion of atrial fibrillation (AF) to sinus rhythm are poorly understood. This study describes the dynamic behavior of electrophysiological parameters and conduction patterns leading to spontaneous and pharmacological AF termination. Methods: Five independent groups of goats were investigated: (1) spontaneous termination of AF, and drug-induced terminations of AF by various potassium channel inhibitors: (2) AP14145, (3) PA-6, (4) XAF-1407, and (5) vernakalant. Bi-atrial contact mapping was performed during an open chest surgery and intervals with continuous and discrete atrial activity were determined. AF cycle length (AFCL), conduction velocity and path length were calculated for each interval, and the final conduction pattern preceding AF termination was evaluated. Results: AF termination was preceded by a sudden episode of discrete activity both in the presence and absence of an antiarrhythmic drug. This episode was accompanied by substantial increases in AFCL and conduction velocity, resulting in prolongation of path length. In 77% ± 4% of all terminations the conduction pattern preceding AF termination involved medial to lateral conduction along Bachmann's bundle into both atria, followed by anterior to posterior conduction. This finding suggests conduction block in the interatrial septum and/or pulmonary vein area as final step of AF termination. Conclusion: AF termination is preceded by an increased organization of fibrillatory conduction. The termination itself is a sudden process with a critical role for the interplay between spatiotemporal organization and anatomical structure.

physiology
Predicting Spontaneous Termination of Atrial Fibrillation Based on Analysis of Standard Electrocardiograms: A Systematic Review

Brandon Wadforth,Jing Soong Goh,Kathryn Tiver,Sobhan Salari Shahrbabaki,Ivaylo Tonchev,Dhani Dharmaprani,Anand N. Ganesan

DOI: https://doi.org/10.1111/anec.70025

IF: 1.485

2024-10-27

Annals of Noninvasive Electrocardiology

Abstract:ABSTRACT Background Forward prediction of atrial fibrillation (AF) termination is a challenging technical problem of increasing significance due to rising AF presentations to emergency departments worldwide. The ability to non‐invasively predict which AF episodes will terminate has important implications in terms of clinical decision‐making surrounding treatment and admission, with subsequent impacts on hospital capacity and the economic cost of AF hospitalizations. Methods and Results MEDLINE, EMCare, CINAHL, CENTRAL, and SCOPUS were searched on 29 July 2023 for articles where an attempt to predict AF termination was made using standard surface ECG recordings. The final review included 35 articles. Signal processing techniques fit into three broad categories including machine learning ( n = 14), entropy analysis ( n = 12), and time–frequency/frequency analysis ( n = 9). Retrospectively processed ECG data was used in all studies with no prospective validation studies. Most studies ( n = 33) utilized the same ECG database, which included recordings that either terminated within 1 min or continued for over 1 h. There was no significant difference in accuracy between groups (H(2) = 0.058, p ‐value = 0.971). Only one study assessed recordings earlier than several minutes preceding termination, achieving 92% accuracy using the central 10 s of paroxysmal episodes lasting up to 174. Conclusions No studies attempted to forward predict AF termination in real‐time, representing an opportunity for novel prospective validation studies. Multiple signal processing techniques have proven accurate in predicting AF termination utilizing ECG recordings sourced from a database retrospectively.

cardiac & cardiovascular systems
Impact of Acute Atrial Fibrillation Termination and Prolongation of Atrial Fibrillation Cycle Length on the Outcome of Ablation of Persistent Atrial Fibrillation: A Substudy of the STAR AF II Trial

Simon Kochhäuser,Chenyang Jiang,Timothy R. Betts,Jian Chen,Isabel Deisenhofer,Roberto Mantovan,Laurent Macle,Carlos A. Morillo,Wilhelm Haverkamp,Rukshen Weerasooriya,Jean‐Paul Albenque,Stefano Nardi,Endrj Menardi,Paul Novak,Prashanthan Sanders,Atul Verma

DOI: https://doi.org/10.1016/j.hrthm.2016.12.033

IF: 6.779

2017-01-01

Heart Rhythm

Abstract:Controversy exists about the impact of acute atrial fibrillation (AF) termination and prolongation of atrial fibrillation cycle length (AFCL) during ablation on long-term procedural outcome.The purpose of this study was to analyze the influence of AF termination and AFCL prolongation on freedom from AF in patients from the STAR AF II (Substrate and Trigger Ablation for Reduction of Atrial Fibrillation Trial-Part II) trial.Acute changes in AFCL and AF termination were collected during the index procedure of the STAR AF II trial and compared to recurrence of AF at 18 months. Recurrence was assessed by ECG, Holter (3, 6, 9, 12, 18 months), and weekly transtelephonic ECG monitoring for 18 months.AF terminated in 8% of the pulmonary vein isolation (PVI) arm, 45% in the PVI+complex electrogram arm, and 22% of the PVI+linear ablation arm (P <.001), but freedom from AF did not differ among the 3 groups (P = .15). Freedom from AF was significantly higher in patients who presented to the laboratory in sinus rhythm (SR) compared to those without AF termination (63% vs 44%, P = .007). Patients with AF termination had an intermediate outcome (53%) that was not significantly different from those in SR (P = .84) or those who did not terminate (P = .08). AF termination was a univariable predictor of success (P = .007), but by multivariable analysis, presence of early SR was the strongest predictor of success (hazard ratio 0.67, P = .004). Prolongation of AFCL was not predictive of 18-month freedom from AF.Acute AF termination and prolongation in AFCL did not consistently predict 18-month freedom from AF. Presence of SR before or early during the ablation was the strongest predictor of better outcome.
Atrial Fibrillation Termination as a Predictor for Persistent Atrial Fibrillation Ablation: A Systemic Review and Meta‐Analysis of Prospective Studies

Jialing He,Zhen Zhang,Duan Luo,Xianchen Yang,Guoshu Yang,Hanxiong Liu

DOI: https://doi.org/10.1155/2024/9944490

2024-06-22

Cardiovascular Therapeutics

Abstract:Background: In this systematic review and meta‐analysis, we aimed to validate the predictive role of atrial fibrillation (AF) termination in long‐term arrhythmia recurrence. Method: Our search encompassed databases including MEDLINE, EMBASE, PubMed, and the Cochrane Library up to August 1, 2021. Three independent reviewers conducted screening and data extraction. The data included ablation strategy, recurrence mode, AF termination mode, numbers of patients, and recurrence cases in the termination and nontermination groups. The primary endpoint was the recurrence of atrial arrhythmia at long‐term follow‐up (≥ 12 months). Results: Our analysis included 22 publications, with 11 prospective studies being eligible for further meta‐analysis. Among these, 14 studies reported significantly lower rates of arrhythmia recurrence in the AF termination group compared to the nontermination group. Among seven studies involving 1114 patients that examined single procedure outcomes, the pooled estimated effect was RR 0.78 (95% CI 0.68–1.90) with an I2 value of 57%. Subgroup analysis focusing on termination mode as sinus rhythm yielded a pooled estimated effect of RR 0.74 (95% CI 0.59–0.92) with an I2 value of 47%. Additionally, analysis of seven studies involving 1433 patients for repeat procedures demonstrated a significant preference for the AF termination group (RR 0.83, 95% CI 0.71–0.97, I2 = 84%). Subgroup analysis indicated reduced heterogeneity when the termination mode was sinus rhythm (RR 0.68, 95% CI 0.51–0.90, I2 = 57%). Conclusion: Our study establishes that AF termination serves as an effective predictor for the success of persistent AF ablation procedures. This finding holds potential implications for clinical practice and contributes to our understanding of long‐term arrhythmia recurrence in the context of AF termination.

pharmacology & pharmacy,cardiac & cardiovascular systems
Non-invasive Prediction of Atrial Fibrillation Recurrence by Recurrence Quantification Analysis on the Fibrillation Cycle Length

Xujian Feng,Haonan Chen,Quan Fang,Taibo Chen,Cuiwei Yang

DOI: https://doi.org/10.1016/j.bspc.2024.107037

2025-01-01

Abstract:Objective: The long-term success of atrial fibrillation (AF) ablation remains limited, primarily due to inter- patient variability in AF mechanisms. The ventricular residuals in ECG f-wave extraction, along with the low temporal resolution in Fourier spectral analysis, significantly impact dynamic structure analysis and may compromise the accuracy of AF recurrence prediction. To address these challenges, this work aims to improve the interpretation of recurring patterns in AF cycle length (AFCL) to aid in preoperative patient screening. Methods: The study utilized data from a dataset of 87 patients (77 with persistent AF and 10 with paroxysmal AF). The variability of AFCL was derived from the extracted f-waves of lead V1 in preprocedural 250-second recordings with EEMD-based cycle identification. Recurrence plot indices (RPIs) from recurrence quantification analysis were introduced to characterize the dynamic structure of AFCL variability. A support vector machine prediction model was subsequently applied in 10-fold cross-validation to incorporate multivariate RPIs with feature selection. Results: RPIs showed significant differences between recurrence and non-recurrence patients. In ten-fold cross-validation, the sensitivity, specificity and accuracy of the prediction model were 75%, 100%, 90% for paroxysmal AF, and 66%, 75%, 71% for persistent AF. The recurrence prediction indicated significant differences in AF-free likelihood between patients predicted to recur and those predicted not, yielding p-values of 0.004 for paroxysmal AF and 0.001 for persistent AF. Conclusion: Non-invasive AFCL dynamics analysis showed effective prediction of long-term outcomes, suggesting their potential to aid inpatient selection for optimal AF ablation benefits and reveal recurrence-related AF mechanisms.
Impact of Prolonged Cycle Length Resulting From Conversion of Atrial Fibrillation to Atrial Tachycardia on Ablation Outcome in Persistent Atrial Fibrillation Ablation

Jialing He,Guoshu Yang,Duan Luo,Yongxin Yang,Guijun He,Xianchen Yang,Zhen Zhang

DOI: https://doi.org/10.1155/2024/8880826

2024-06-10

Cardiovascular Therapeutics

Abstract:Background: There is limited available data regarding the impact of cycle length (CL) prolongation when converting atrial fibrillation (AF) to organized atrial tachycardia (AT) and its effect on clinical outcomes. Methods and Method: We retrospectively screened and included a cohort of 132 patients with persistent or long‐standing persistent AF who underwent circumferential pulmonary vein isolation (CPVI) and left atrial substrate modification (LASM) between January 2015 and October 2019. In all 132 consecutive patients, persistent AF was successfully converted into organized AT. For cases with recurrence after a 3‐month blanking period, a repeat procedure was conducted. Results: We observed a notable prolongation in CL after ablation (average increase of 56.6 ± 30 ms). Following a median follow‐up duration of 9.5 ± 5.1 months, 27 patients experienced recurrence. Through receiver operating curve (ROC) analysis, a prolonged CL cut‐off of 42.5 ms was identified, with a specificity of 71% and a sensitivity of 59.4%. Patients were categorized into two groups: those with CL less than 42.5 ms (group A, n = 48) and those with CL more than 42.5 ms (group B, n = 84). The Kaplan–Meier survival curves demonstrated a significantly higher recurrence‐free rate after catheter ablation in group B compared to group A (p = 0.002). Conclusions: Upon termination of persistent AF into AT during ablation, it was found that CL prolongation beyond 42.5 ms was associated with improved freedom from arrhythmia.

pharmacology & pharmacy,cardiac & cardiovascular systems
Duration of Atrial Fibrillation Persistence: Implications for Recurrence Risk after Catheter Ablation and Efficacy of Additional Substrate Ablation

Yasuharu Matsunaga-Lee,Koichi Inoue,Nobuaki Tanaka,Masaharu Masuda,Tetsuya Watanabe,Nobuhiko Makino,Yasuyuki Egami,Takafumi Oka,Hitoshi Minamiguchi,Miwa Miyoshi,Masato Okada,Takashi Kanda,Yasuhiro Matsuda,Masato Kawasaki,Shodai Kawanami,Kohei Ukita,Akito Kawamura,Koji Yasumoto,Masaki Tsuda,Naotaka Okamoto,Masamichi Yano,Masami Nishino,Akihiro Sunaga,Yohei Sotomi,Tomoharu Dohi,Daisaku Nakatani,Shungo Hikoso,Yasushi Sakata

DOI: https://doi.org/10.1016/j.hrthm.2024.01.053

IF: 6.779

2024-02-04

Heart Rhythm

Abstract:Background The optimal duration of atrial fibrillation (AF) persistence for predicting poor outcomes post-catheter ablation of longstanding-persistent AF (LsAF) and the best ablation strategy for these patients remain unclear. Objective We aimed to assess the impact of the duration of AF persistence on outcomes after catheter ablation of AF. Methods We analyzed the EARNEST-PVI trial data comparing pulmonary vein isolation alone (PVI- alone) and with additional ablation of linear and/or defragmentation (PVI-plus) in persistent AF (PerAF). Patients who received catheter ablation using contact force sensing catheter were enrolled in the present study. In patients with LsAF, the optimal cutoff duration of AF persistence was evaluated. Using the threshold, patients with LsAF were divided into two groups and compared with PerAF (<1 year) for arrhythmia-free survival after a 3-month blanking period. Results The optimal cutoff duration was 2.4 years. Of 458 patients, arrhythmia-free survival rates for LsAF (1-2.4 years) were comparable to PerAF (HR 1.01, 95% CI 0.67-1.52). However, LsAF (>2.4 years) had a higher recurrence risk compared to PerAF (HR 2.22, 95% CI 1.42-3.47). In LsAF (>2.4 years), the PVI-plus strategy showed advantages over the PVI-alone strategy (HR 0.36, 95% CI 0.14-0.89). However, the interaction effect between LsAF (1-2.4 years) and LsAF (>2.4 years) did not reach statistical significance (p=0.116). Conclusion While LsAF (1-2.4 years) has similar outcomes to PerAF, LsAF (>2.4 years) was linked to higher arrhythmia recurrence risks. For LsAF (>2.4 years), the PVI-plus strategy showed a potential to be superior to the PVI-alone strategy.

cardiac & cardiovascular systems
What determines the optimal pharmacological treatment of atrial fibrillation? Insights from in silico trials in 800 virtual atria

Albert Dasí,Michael T B Pope,Rohan S Wijesurendra,Tim R Betts,Rafael Sachetto,Alfonso Bueno-Orovio,Blanca Rodriguez

DOI: https://doi.org/10.1113/JP284730

Abstract:The best pharmacological treatment for each atrial fibrillation (AF) patient is unclear. We aim to exploit AF simulations in 800 virtual atria to identify key patient characteristics that guide the optimal selection of anti-arrhythmic drugs. The virtual cohort considered variability in electrophysiology and low voltage areas (LVA) and was developed and validated against experimental and clinical data from ionic currents to ECG. AF sustained in 494 (62%) atria, with large inward rectifier K+ current (IK1 ) and Na+ /K+ pump (INaK ) densities (IK1 0.11 ± 0.03 vs. 0.07 ± 0.03 S mF-1 ; INaK 0.68 ± 0.15 vs. 0.38 ± 26 S mF-1 ; sustained vs. un-sustained AF). In severely remodelled left atrium, with LVA extensions of more than 40% in the posterior wall, higher IK1 (median density 0.12 ± 0.02 S mF-1 ) was required for AF maintenance, and rotors localized in healthy right atrium. For lower LVA extensions, rotors could also anchor to LVA, in atria presenting short refractoriness (median L-type Ca2+ current, ICaL , density 0.08 ± 0.03 S mF-1 ). This atrial refractoriness, modulated by ICaL and fast Na+ current (INa ), determined pharmacological treatment success for both small and large LVA. Vernakalant was effective in atria presenting long refractoriness (median ICaL density 0.13 ± 0.05 S mF-1 ). For short refractoriness, atria with high INa (median density 8.92 ± 2.59 S mF-1 ) responded more favourably to amiodarone than flecainide, and the opposite was found in atria with low INa (median density 5.33 ± 1.41 S mF-1 ). In silico drug trials in 800 human atria identify inward currents as critical for optimal stratification of AF patient to pharmacological treatment and, together with the left atrial LVA extension, for accurately phenotyping AF dynamics. KEY POINTS: Atrial fibrillation (AF) maintenance is facilitated by small L-type Ca2+ current (ICaL ) and large inward rectifier K+ current (IK1 ) and Na+ /K+ pump. In severely remodelled left atrium, with low voltage areas (LVA) covering more than 40% of the posterior wall, sustained AF requires higher IK1 and rotors localize in healthy right atrium. For lower LVA extensions, rotors can also anchor to LVA, if the atria present short refractoriness (low ICaL ) Vernakalant is effective in atria presenting long refractoriness (high ICaL ). For short refractoriness, atria with fast Na+ current (INa ) up-regulation respond more favourably to amiodarone than flecainide, and the opposite is found in atria with low INa . The inward currents (ICaL and INa ) are critical for optimal stratification of AF patient to pharmacological treatment and, together with the left atrial LVA extension, for accurately phenotyping AF dynamics.
Natural history of atrial fibrillation

K Hirosawa,M Sekiguchi,H Kasanuki,S Kimata,N Kaneko,K Nakamura,M Aosaki,S Takahashi,M Kondo

Abstract:The clinical significance of atrial fibrillation was analyzed in cases with chronic or acute heart disease and its significance at the acute and chronic stages of the disease was investigated in various disease groups. The types of disease, number of patients, and incidence of atrial fibrillation were: atrial septal defect (92, 14.1%), mitral valve disease (128, 79.7%), nonrheumatic valvular disease (32, 56.2%), aortic regurgitation (71, 2.8%), aortic stenosis (10, 10.0%), hypertrophic cardiomyopathy (181, 11.6%), dilated cardiomyopathy (111, 37.8%), acute myocardial infarction (823, 9.0%), healthy subjects (31,886, 0.3%). A histopathological and electron-microscopic evaluation of the atrial heart muscle revealed that the advancement of the morphological changes was closely related to the occurrence of atrial fibrillation. Decrease in size of F waves in the electrocardiogram correlated well with the extent of right and left atrial fibrosis. Also, it was noteworthy that the atrial fibrillation in cases with dissecting aneurysm (n = 60) was an expression of the myocardial damage due to the infiltration of the bleeding into the right atrium. Intra-atrial electrogram in 48 patients with various heart diseases revealed that the electric potentials obtained from various parts of the atrium varied to a great extent and finally the patient's condition transformed to that of atrial standstill. We conclude that atrial fibrillation is an expression of some important aspect of the progression of heart disease and is not directly associated with hemodynamic overloading to the atrium. A strategy for quinidine treatment was also introduced.
Genital infection and sperm agglutinating antibodies in infertile men.

E. Quesada,C. D. Dukes,G. Deen,R. Franklin

DOI: https://doi.org/10.1016/S0022-5347(17)62650-8

Abstract:
Atrial fibrillation recurrence after drug-induced typical atrial flutter ablation

Alberto Bandini,Paolo Golia,Denis Pantoli,Marcello Galvani,Franco Rusticali

Abstract:Background: Catheter ablation of typical atrial flutter (AFL) occurring in patients who take antiarrhythmic drugs for atrial fibrillation (AF) has been proposed as a curative approach for AF. The aim of this study was to evaluate the efficacy of this technique. Methods: Forty-six consecutive patients (30 males, 16 females, mean age 67 +/- 9 years) with paroxysmal or persistent AF were submitted to right atrial isthmus ablation: 1) 33 patients (group 1) in whom typical AFL spontaneously occurred during oral treatment with propafenone (n = 19), flecainide (n = 9) or amiodarone (n = 6); 2) 13 patients (group 2) submitted to electrophysiological study while taking oral propafenone (n = 3), flecainide (n = 8) or amiodarone (n = 1), in whom sustained AFL was induced (n = 9) or AF was induced and AFL was obtained by intravenous administration of class IC drugs (n = 4). The same antiarrhythmic drug which induced the conversion of AF into AFL was administered after ablation. Results: During a follow-up of 20 +/- 18 months (range 1-78 months), 23 patients (50%) remained asymptomatic and free from AF recurrences. Fifteen patients (33%) with AF recurrences reported a reduction in arrhythmia-related symptoms. Eight patients (17%) did not show symptomatic improvement. These results did not significantly differ between group 1 and group 2. The duration of follow-up was significantly longer in patients with AF recurrence. Among several clinical, echocardiographic and electrophysiological parameters, only atrial enlargement and the absence of structural heart disease were independently associated with AF recurrence. Conclusions: In selected patients with AF and drug-induced AFL, right atrial isthmus ablation and prosecution of the drug treatment is a safe and feasible approach, which totally eliminates or reduces symptomatic AF recurrences in one half and one third of patients, respectively. However, the number of AF-free patients tends to decrease over time.
Abstract 13576: Long-Term Serial Changes in Echocardiographic Parameters in Patients With Heart Failure With Preserved Ejection Fraction After Catheter Ablation for Atrial Fibrillation

Taiji Okada,Atsushi Kobori,Madoka Sano,Junichi Ooka,Murai Ryousuke,Yasuhiro Sasaki,Toshiaki Toyota,Tomohiko Taniguchi,Kitae Kim,Natsuhiko Ehara,Makoto Kinoshita,Tomoko Tani,Yutaka Furukawa

DOI: https://doi.org/10.1161/circ.148.suppl_1.13576

IF: 37.8

2023-11-07

Circulation

Abstract:Background: Heart failure with preserved ejection fraction (HFpEF) is frequently complicated by atrial fibrillation (AF). Catheter ablation for AF is an effective method for restoring and maintaining sinus rhythm (SR). However, there is limited data on the serial changes in echocardiographic parameters in patients with HFpEF after ablation. Hypothesis: The serial changes in echocardiographic parameters after ablation for AF depend not only on baseline rhythm but also on the presence of HFpEF. Methods: A retrospectively review was conducted on 1109 out of 2123 patients who had serial echocardiographic data available before the ablation procedure and at 1-year, 2-year, and 3-year follow-ups. The changes in echocardiographic parameters were assessed using repeated measures ANOVA with a Greenhouse-Geisser correction and Bonferroni tests in four groups, which were divided according to baseline rhythm and HFpEF. HFpEF was defined as an HFA-PEFF score ≥ 5 or 2-4 and left atrial pressure ≥ 15 mmHg at the time of catheter ablation. Results: The prevalence of HFpEF was 51.9%, and paroxysmal AF was present in 65%. Left atrial volume index (LAVI) was larger at baseline in patients with AF and significant decreased after ablation in all groups. The trend of left atrial emptying fraction (LAEF) increased in patients with baseline AF until 1year later, while in patients with baseline SR and HFpEF, LAEF gradually declined even after catheter ablation. The trend of left ventricular ejection fraction increased in patients with baseline AF. The trend of mean E/E’ mildly increased after ablation in all groups. There were significant differences between HFpEF and non-HFpEF. (Figure) Conclusions: Catheter ablation was associated with changes of LA size, function and left ventricular function. Baseline rhythm and the presence of HFpEF play a complex role in the course of cardiac function after ablation.

cardiac & cardiovascular systems,peripheral vascular disease
Factors influencing early recurrence of atrial fibrillation among elderly patients following radiofrequency catheter ablation and the impact of different antiarrhythmic regimens

Changdong Fei,Caitong Zhao,Yan Ma,Yupeng Liu,Renzheng Chen,Hualin Zhang

DOI: https://doi.org/10.3389/fmed.2024.1393208

IF: 3.9

2024-06-27

Frontiers in Medicine

Abstract:Background Patients with atrial fibrillation (AF) who undergo radiofrequency catheter ablation (RFCA) necessitate the administration of antiarrhythmic drugs to prevent early recurrence. The clinical outcomes among these patients may be influenced by varying antiarrhythmic regimens. Objectives To identify the risk factors associated with early recurrence and compare the clinical outcomes among different antiarrhythmic regimens in elderly patients with AF following radiofrequency catheter ablation (RFCA) during a 3-month period. Methods A retrospective observational study encompassed 420 elderly patients with AF following RFCA. Baseline data were collected during the initial postoperative visit and clinical outcomes were carefully monitored over a 3-month follow-up period. Logistic regression and Cox-proportional hazard regression analyses were performed to investigate the relationship between various antiarrhythmic regimens and the clinical outcomes. Results Multivariate logistic regression analysis revealed that age ( p = 0.001), left atrial diameter ( p < 0.001), left ventricular diameter ( p = 0.015), reactive hyperemia index (RHI) ( p < 0.001), antiarrhythmic drug ( p < 0.001) and hs-cTnI ( p = 0.017) were independent risk factors of early recurrence. Furthermore, in cox survival regression analysis model, survival rate of early recurrence in the amiodarone group was higher than in the propafenone group (HR 2.30, 95%CI 1.17–4.53, p = 0.016) and in the sotalol group (HR 3.60, 95%CI 2.17–5.95, p < 0.001). Compared to the amiodarone group, the incidence of liver dysfunction was lower in the dronedarone group ( p = 0.046) and the propafenone group ( p = 0.021). The incidence of bradyarrhythmia ( p = 0.003), QT interval prolongation ( p = 0.035) and atrioventricular transmission block ( p = 0.021) were higher in the sotalol group than in the amiodarone group. Conclusion RHI was identified as an independent risk factor for early recurrence among elderly AF patients after RFCA. Compared to amiodarone, propafenone and sotalol exhibited an elevated risk of early recurrence. Although there was no significant difference in early recurrence between amiodarone and dronedarone, dronedarone emerged as the preferred option due to its lower frequency of adverse drug reactions than amiodarone.

medicine, general & internal
[Audiometric changes in epileptics].

F. Perrella,A. Marotta,G. Santorelli

Abstract:
Does the Aged Care Funding Instrument provide increased funding in residential care? Comparisons with the Residential Classification Scale

Geoffrey ZP Chan,Collin KL Chin,D. McKitrick,R. Warne

DOI: https://doi.org/10.1111/ajag.12036

2014-06-01

Australasian Journal on Ageing

Abstract:To determine whether the Aged Care Funding Instrument (ACFI) provides more funding than the Residential Classification Scale (RCS) for residents in the Hellenic Residential Care Facility.
[Demonstration of the fibrillatory effect of class I anti-arrhythmia agents based on the time of fibrillation onset and electrical threshold in myocardial ischemia]

Q Timour,J F Aupetit,J L Loufoua-Moundanga,L Barral-Cadière,M Freysz,G Faucon

Therapie

Abstract:In recent clinical studies, certain class I antiarrhythmic drugs (flecaïnide, lidocaïne) appeared to be responsible for an increase in mortality, when used to treat ventricular arrhythmias occurring after or during infarction. Experimentally, in pigs whose rate of ventricular beats was kept constant by pacing, all the studied class I antiarrhythmic drugs, disopyramide, lidocaïne and flecaïnide, proved to be to a variable degree capable of shortening time to onset of fibrillation (TOF) elicited by controlled myocardial ischemia. Fibrillation occurred at the end of the decline, under the influence of ischemia, of electrical fibrillation threshold (EFT) down to near 0 mA. The fall of EFT to this level was checked by ischemias of increasing duration to be hastened by the cited antiarrhythmic drugs. In other words, these drugs exert a profibrillatory effect in the ischemic heart.
Effect of flecainide on atrial fibrillatory rate in a large animal model with induced atrial fibrillation

Eva Z. Hesselkilde,Helena Carstensen,Maria M. Haugaard,Jonas Carlson,Steen Pehrson,Thomas Jespersen,Rikke Buhl,Pyotr G. Platonov

DOI: https://doi.org/10.1186/s12872-017-0720-1

IF: 2.174

2017-12-01

BMC Cardiovascular Disorders

Abstract:BackgroundAtrial fibrillatory cycle length has been considered one of the indices of atrial electrical remodelling during atrial fibrillation (AF), which can be assessed from surface ECG by computer-assisted calculation of atrial fibrillatory rate (AFR). Horses have been suggested as a bona fide model for AF studies since horses too, develop lone AF, however data on AF characteristics in horses are extremely sparse and non-invasive characterization of AF complexity using surface ECG processing has not been reported.AimThe aim was to study characteristics of induced AF and its modification by flecainide.MethodsThe study group consisted on 3 horses with spontaneous persistent AF and 13 with pace-induced AF. Seven horses were treated with saline (control) and eight with flecainide (2 mg/kg). ECGs were analysed using spatiotemporal cancellation of QRST complexes and calculation of AFR from the residual atrial signal.ResultsAt AF onset, AFR was 295 ± 52 fibrillations per minute (fpm) in the horses with induced AF treated with flecainide, 269 ± 36 fpm in the control group (ns), and 364 ± 26 fpm in the horses with spontaneous persistent AF (P < 0.05 compared to the control group). Flecainide caused a decrease in AFR in all animals and restored sinus rhythm in the animals with induced AF. In the control animals, AFR increased from 269 ± 36 fpm to a plateau of 313 ± 14 fpm before decreasing to 288 ± 28 fpm during the last 10% of the AF episodes preceding spontaneous conversion (P < 0.05).ConclusionAFR in horses with induced AF resembles AFR in humans with paroxysmal AF. Flecainide caused a rapid decrease in AFR in all horses, further supporting the method to be a non-invasive technique to study the effect of antiarrhythmic compounds.

cardiac & cardiovascular systems
Autonomic modulation of complex fractionated atrial electrograms in patients with paroxysmal atrial fibrillation

Demosthenes Katritsis,Demetrios Sougiannis,Kimon Batsikas,Eleftherios Giazitzoglou,John Mersinias,George Katritsis,Sunny S Po

DOI: https://doi.org/10.1007/s10840-011-9558-0

Abstract:Aims: In patients with atrial fibrillation (AF), complex fractionated atrial electrograms (CFAE) have been shown to be located at the anatomic sites of ganglionated plexi (GP). This study aimed at investigating the contribution of parasympathetic activity to formation of CFAE. Methods: Twelve patients (aged 55 ± 11 years, five females) with paroxysmal AF were studied. Following electroanatomical mapping of the left atrium, GP were identified by high frequency stimulation (HFS), 12-24 V in a conscious state, and assessment of CFAE during AF was performed with the use of dedicated software. Fractionated activity was measured at each GP site by interval confidence levels (ICL) and average complex interval (ACI), and was compared to measurements obtained 1 min after intravenous administration of 1 mg of atropine. Results: In total, 30 out of 48 GP could be identified by HFS. CFAE were detected at all sites where GP were found. ICL was significantly lower after atropine administration only at ARGP (5.4 ± 2.7 vs. 2.8 ± 2.1, p = 0.028), whereas no significant difference was detected pre- or post-atropine at any GP in ACI. Considering all fractionation values from the four GP, a statistically significant reduction of the ICL score was observed (4.6 ± 3.4 vs. 5.8 ± 2.9, p = 0.03) after atropine administration, whereas no significant differences were observed in the ACI score (144.5 ± 24.0 post-atropine vs. 146.7 ± 27.7 pre-atropine, p = 0.620). The average RR interval became significantly shorter post-atropine (575.8 ± 139.1 vs. 637.2 ± 158.7, p = 0.004). Conclusion: Our data do not support the hypothesis that parasympathetic activity plays the dominant role in electrogram fractionation.
Model-based estimation of AV-nodal refractory period and conduction delay trends from ECG

Mattias Karlsson,Pyotr G. Platonov,Sara R. Ulimoen,Frida Sandberg,Mikael Wallman

DOI: https://doi.org/10.3389/fphys.2023.1287365

IF: 4

2024-01-13

Frontiers in Physiology

Abstract:Introduction: Atrial fibrillation (AF) is the most common arrhythmia, associated with significant burdens to patients and the healthcare system. The atrioventricular (AV) node plays a vital role in regulating heart rate during AF by filtering electrical impulses from the atria. However, it is often insufficient in regards to maintaining a healthy heart rate, thus the AV node properties are modified using rate-control drugs. Moreover, treatment selection during permanent AF is currently done empirically. Quantifying individual differences in diurnal and short-term variability of AV-nodal function could aid in personalized treatment selection. Methods: This study presents a novel methodology for estimating the refractory period (RP) and conduction delay (CD) trends, and their uncertainty in the two pathways of the AV node during 24 h using non-invasive data. This was achieved by utilizing a network model together with a problem-specific genetic algorithm and an approximate Bayesian computation algorithm. Diurnal variability in the estimated RP and CD was quantified by the difference between the daytime and nighttime estimates, and short-term variability was quantified by the Kolmogorov-Smirnov distance between adjacent 10-min segments in the 24-h trends. Additionally, the predictive value of the derived parameter trends regarding drug outcome was investigated using several machine learning tools. Results: Holter electrocardiograms from 51 patients with permanent AF during baseline were analyzed, and the predictive power of variations in RP and CD on the resulting heart rate reduction after treatment with four rate control drugs was investigated. Diurnal variability yielded no correlation to treatment outcome, and no prediction of drug outcome was possible using the machine learning tools. However, a correlation between the short-term variability for the RP and CD in the fast pathway and resulting heart rate reduction during treatment with metoprolol ( ρ = 0.48, p < 0.005 in RP, ρ = 0.35, p < 0.05 in CD) were found. Discussion: The proposed methodology enables non-invasive estimation of the AV node properties during 24 h, which—indicated by the correlation between the short-term variability and heart rate reduction—may have the potential to assist in treatment selection.

physiology

Association between accelerometer-determined physical activity and flavonoid-rich fruit and vegetable consumption among a national sample of U.S. adults

Potential Maintenance Mechanism in Atrial Fibrillation Patients Subject to Different Treatment Procedures: A Preliminary Study Based on a Human Atrial Model

Analysis of drug-induced and spontaneous cardioversions reveals similar patterns leading to termination of atrial fibrillation

Predicting Spontaneous Termination of Atrial Fibrillation Based on Analysis of Standard Electrocardiograms: A Systematic Review

Impact of Acute Atrial Fibrillation Termination and Prolongation of Atrial Fibrillation Cycle Length on the Outcome of Ablation of Persistent Atrial Fibrillation: A Substudy of the STAR AF II Trial

Atrial Fibrillation Termination as a Predictor for Persistent Atrial Fibrillation Ablation: A Systemic Review and Meta‐Analysis of Prospective Studies

Non-invasive Prediction of Atrial Fibrillation Recurrence by Recurrence Quantification Analysis on the Fibrillation Cycle Length

Impact of Prolonged Cycle Length Resulting From Conversion of Atrial Fibrillation to Atrial Tachycardia on Ablation Outcome in Persistent Atrial Fibrillation Ablation

Duration of Atrial Fibrillation Persistence: Implications for Recurrence Risk after Catheter Ablation and Efficacy of Additional Substrate Ablation

What determines the optimal pharmacological treatment of atrial fibrillation? Insights from in silico trials in 800 virtual atria

Natural history of atrial fibrillation

Genital infection and sperm agglutinating antibodies in infertile men.

Atrial fibrillation recurrence after drug-induced typical atrial flutter ablation

Abstract 13576: Long-Term Serial Changes in Echocardiographic Parameters in Patients With Heart Failure With Preserved Ejection Fraction After Catheter Ablation for Atrial Fibrillation

Factors influencing early recurrence of atrial fibrillation among elderly patients following radiofrequency catheter ablation and the impact of different antiarrhythmic regimens

[Audiometric changes in epileptics].

Does the Aged Care Funding Instrument provide increased funding in residential care? Comparisons with the Residential Classification Scale

[Demonstration of the fibrillatory effect of class I anti-arrhythmia agents based on the time of fibrillation onset and electrical threshold in myocardial ischemia]

Effect of flecainide on atrial fibrillatory rate in a large animal model with induced atrial fibrillation

Autonomic modulation of complex fractionated atrial electrograms in patients with paroxysmal atrial fibrillation

Model-based estimation of AV-nodal refractory period and conduction delay trends from ECG